<p style=/line-height:25px/>TC-DAPK 6 is an oxazalone compound that acts as a potent, ATP-competitive, and highly selective death-associated protein kinase (DAPK) inhibitor (IC50 = 69 and 225 nM against DAPK1 and DAPK3, respectively, with 10 uM ATP).<br>IC50 value: 69 nM (DAPK1); 225 nM (DAPK3)<br>Target: DAPK1; DAPK3<br>Death-associated protein kinase (DAPK) is a serine/threonine protein kinase implicated in diverse programmed cell death pathways. DAPK is a promising target protein for the treatment of ischemic diseases. TC-DAPK 6 is an oxazalone compound that acts as a potent, ATP-competitive, and highly selective death-associated protein kinase (DAPK) inhibitor (IC50 = 69 and 225 nM against DAPK1 and DAPK3, respectively, with 10 uM ATP); while exhibiting much reduced or no activity against a panel of 48 other kinases even at concentrations as high as 10 uM.</p>
Catalog Number | I003122 |
CAS Number | 315694-89-4 |
Synonyms | (4E)-2-[(E)-2-phenylethenyl]-4-(pyridin-3-ylmethylidene)-1,3-oxazol-5-one |
Molecular Formula | C17H12N2O2 |
Purity | ≥95% |
Target | DAPK |
Solubility | Soluble to 50 mM in DMSO |
Storage | Store at -20°C |
IC50 | 69 nM (DAPK1); 225 nM (DAPK3) |
Reference | <p style=/line-height:25px/> |